Molecular Medicine

, Volume 23, Issue 1, pp 258–271 | Cite as

miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha

  • Li-Li Liu
  • Dahu Li
  • Yun-Ling He
  • Yan-Zhao Zhou
  • Sheng-Hui Gong
  • Li-Ying Wu
  • Yong-Qi Zhao
  • Xin Huang
  • Tong Zhao
  • Lun Xu
  • Kui-Wu Wu
  • Ming-Gao Li
  • Ling-Ling Zhu
  • Ming Fan
Research Article


The kidney is vulnerable to hypoxia-induced injury. One of the mechanisms underlying this phenomenon is cell apoptosis triggered by hypoxia-inducible factor-1- α (HIF-1α) activation. MicroRNA-210 (miR-210) is known to be induced by HIF-1α and can regulate various pathological processes, but its role in hypoxic kidney injury remains unclear. Here, in both rat systemic hypoxia and local kidney hypoxia models, we found miR-210 levels were upregulated significantly in injured kidney, especially in renal tubular cells. A similar increase was observed in hypoxia-treated human renal tubular HK-2 cells. We also verified that miR-210 can directly suppress HIF-1α expression by targeting the 3′ untranslated region of HIF-1α mRNA in HK-2 cells in severe hypoxia. Accordingly, miR-210 overexpression caused significant inhibition of the HIF-1α pathway and attenuated apoptosis caused by hypoxia, while miR-210 knockdown exerted the opposite effect. Taken together, our findings verify that miR-210 is involved in the molecular response in hypoxic kidney lesions in vivo and attenuates hypoxia-induced renal tubular cell apoptosis by targeting HIF-1α directly and suppressing HIF-1α pathway activation in vitro.



This work was supported by the grants from the Natural Science Foundation of China (Nos. 81430044 and 31271205) and the National Basic Research Program of China (Nos. 2011CB910800 and 2012CB518200).

Supplementary material

10020_2017_2301258_MOESM1_ESM.pdf (279 kb)
Supplementary material, approximately 279 KB.


  1. 1.
    Majmundar AJ, Wong WJ, Simon MC. (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell. 40:294–309.CrossRefGoogle Scholar
  2. 2.
    Semenza GL. (2012) Hypoxia-inducible factors in physiology and medicine. Cell. 148:399–408.CrossRefGoogle Scholar
  3. 3.
    Valtin H. (1983) Renal Function: Mechanisms Preserving Fluid and Solute Balance in Health. Boston: Little Brown.Google Scholar
  4. 4.
    Legrand M, Mik EG, Johannes T, Payen D, Ince C. (2008) Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol. Med. 14:502–16.CrossRefGoogle Scholar
  5. 5.
    Horkan CM, et al. (2015) The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study. Crit. Care Med. 43:354–64.CrossRefGoogle Scholar
  6. 6.
    Masewu A, et al. (2016) Acute kidney injury is a powerful independent predictor of mortality in critically ill patients: a multicenter prospective cohort study from Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 17:118.CrossRefGoogle Scholar
  7. 7.
    Semenza GL, et al. (2000) Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv. Exp. Med. Biol. 475:123–30.CrossRefGoogle Scholar
  8. 8.
    Thadhani R, Pascual M, Bonventre JV. (1996) Acute renal failure. N. Engl. J. Med. 334:1448–60.CrossRefGoogle Scholar
  9. 9.
    Vaidya VS, Ferguson MA, Bonventre JV. (2008) Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48:463–93.CrossRefGoogle Scholar
  10. 10.
    Zhu Q, et al. (2011) Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension. 58:657–64.CrossRefGoogle Scholar
  11. 11.
    Nangaku M, Eckardt KU. (2007) Hypoxia and the HIF system in kidney disease. J. Mol. Med. (Berl). 85:1325–30.CrossRefGoogle Scholar
  12. 12.
    Kimura K, et al. (2008) Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am. J. Physiol. Renal Physiol. 295:F1023–9.CrossRefGoogle Scholar
  13. 13.
    Althaus J, et al. (2006) Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem. Int. 48:687–95.CrossRefGoogle Scholar
  14. 14.
    An WG, et al. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 392:405–8.CrossRefGoogle Scholar
  15. 15.
    Mao S, Huang S. (2013) The signaling pathway of hypoxia inducible factor and its role in renal diseases. J. Recept. Signal Transduct. Res. 33:344–8.CrossRefGoogle Scholar
  16. 16.
    Bruning U, et al. (2011) MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 31:4087–96.CrossRefGoogle Scholar
  17. 17.
    Chamboredon S, et al. (2011) Hypoxia-inducible factor-1alpha mRNA: a new target for destabilization by tristetraprolin in endothelial cells. Mol. Biol. Cell. 22:3366–78.CrossRefGoogle Scholar
  18. 18.
    Henze AT, et al. (2010) Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 70:357–66.CrossRefGoogle Scholar
  19. 19.
    Leung AK, Sharp PA. (2010) MicroRNA functions in stress responses. Mol. Cell. 40:205–15.CrossRefGoogle Scholar
  20. 20.
    Chan YC, Banerjee J, Choi SY, Sen CK. (2012) miR-210: the master hypoxamir. Microcirculation. 19:215–23.CrossRefGoogle Scholar
  21. 21.
    Huang X, et al. (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell. 35:856–67.CrossRefGoogle Scholar
  22. 22.
    Kelly TJ, Souza AL, Clish CB, Puigserver P. (2011) A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol. Cell. Biol. 31:2696–706.CrossRefGoogle Scholar
  23. 23.
    Wang H, et al. (2014) Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat. Immunol. 15:393–401.CrossRefGoogle Scholar
  24. 24.
    Rosenberger C, et al. (2002) Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J. Am. Soc. Nephrol. 13:1721–32.CrossRefGoogle Scholar
  25. 25.
    Patschan D, Patschan S, Gobe GG, Chintala S, Goligorsky MS. (2007) Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J. Am. Soc. Nephrol. 18:1516–24.CrossRefGoogle Scholar
  26. 26.
    Kapitsinou PP, et al. (2012) Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury. Am. J. Physiol. Renal Physiol. 302:F1172–9.CrossRefGoogle Scholar
  27. 27.
    Malhotra R, Tyson DW, Rosevear HM, Brosius FC 3rd. (2008) Hypoxia-inducible factor-1alpha is a critical mediator of hypoxia induced apoptosis in cardiac H9c2 and kidney epithelial HK-2 cells. BMC Cardiovasc Disord. 8:9.CrossRefGoogle Scholar
  28. 28.
    Singbartl K, Joannidis M. (2015) Short-term effects of acute kidney injury. Crit. Care Clin. 31:751–62.CrossRefGoogle Scholar
  29. 29.
    Bhatt K, Mi QS, Dong Z. (2011) microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am. J. Physiol. Renal Physiol. 300:F602–10.CrossRefGoogle Scholar
  30. 30.
    Giannakakis A, et al. (2008) miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7:255–64.CrossRefGoogle Scholar
  31. 31.
    Nakada C, et al. (2011) Overexpression of miR-210, a downstream target of HIF1alpha, causes centrosome amplification in renal carcinoma cells. J. Pathol. 224:280–8.CrossRefGoogle Scholar
  32. 32.
    Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM. (2010) The VHL-dependent regulation of microRNAs in renal cancer. BMC Med. 8:64.CrossRefGoogle Scholar
  33. 33.
    Zhao A, Li G, Peoc’h M, Genin C, Gigante M. (2013) Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp. Mol. Pathol. 94:115–20.CrossRefGoogle Scholar
  34. 34.
    Chen X, et al. (2008) Characterization of micro-RNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.CrossRefGoogle Scholar
  35. 35.
    Semenza GL. (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol. 9:47–71.CrossRefGoogle Scholar
  36. 36.
    Epstein AC, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:43–54.CrossRefGoogle Scholar
  37. 37.
    Uchida T, et al. (2004) Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J. Biol. Chem. 279:14871–8.CrossRefGoogle Scholar
  38. 38.
    Cascio S, et al. (2010) miR-20b modulates VEGF expression by targeting HIF-1alpha and STAT3 in MCF-7 breast cancer cells. J. Cell Physiol. 224:242–9.PubMedGoogle Scholar
  39. 39.
    Cha ST, et al. (2010) MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res. 70:2675–85.CrossRefGoogle Scholar
  40. 40.
    Lei Z, et al. (2009) Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One. 4:e7629.CrossRefGoogle Scholar
  41. 41.
    Rane S, et al. (2009) Downregulation of miR-199a depresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 104:879–86.CrossRefGoogle Scholar
  42. 42.
    Taguchi A, et al. (2008) Identification of hypoxia-inducible factor-1alpha as a novel target for miR-17–92 microRNA cluster. Cancer Res. 68:5540–5.CrossRefGoogle Scholar
  43. 43.
    Camps C, et al. (2008) hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14:1340–8.CrossRefGoogle Scholar
  44. 44.
    Carmeliet P, et al. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:485–90.CrossRefGoogle Scholar
  45. 45.
    Krick S, et al. (2005) Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells. Am. J. Respir. Cell Mol. Biol. 32:395–403.CrossRefGoogle Scholar
  46. 46.
    Greijer AE, van der Wall E. (2004) The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57:1009–14.CrossRefGoogle Scholar
  47. 47.
    Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. (2001) HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:6669–73.PubMedGoogle Scholar
  48. 48.
    Bruick RK. (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA. 97:9082–7.CrossRefGoogle Scholar
  49. 49.
    Wang F, et al. (2013) miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res. 11:657–67.CrossRefGoogle Scholar
  50. 50.
    Wang EY, et al. (2013) p53 mediates autophagy and cell death by a mechanism contingent on Bnip3. Hypertension. 62:70–7.CrossRefGoogle Scholar
  51. 51.
    Zaccagnini G, et al. (2014) Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia. Antioxid. Redox. Signal. 21:1177–88.CrossRefGoogle Scholar
  52. 52.
    Zeng LL, et al. (2016) Lentivirus-mediated overexpression of microRNA-210 improves long-term outcomes after focal cerebral ischemia in mice. CNS Neurosci. Ther. 22:961–9.CrossRefGoogle Scholar
  53. 53.
    Hu S, et al. (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation. 122:S124–31.CrossRefGoogle Scholar
  54. 54.
    Lorenzen JM, et al. (2011) Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J. Am. Soc. Nephrol. 6:1540–6.CrossRefGoogle Scholar
  55. 55.
    Aguado-Fraile E, et al. (2015) A pilot study identifying a set of microRNAs as precise diagnostic biomarkers of acute kidney injury. PLoS One. 10:e0127175.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2017

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (

Authors and Affiliations

  • Li-Li Liu
    • 1
    • 2
  • Dahu Li
    • 1
  • Yun-Ling He
    • 1
  • Yan-Zhao Zhou
    • 1
  • Sheng-Hui Gong
    • 1
  • Li-Ying Wu
    • 1
  • Yong-Qi Zhao
    • 1
  • Xin Huang
    • 1
  • Tong Zhao
    • 1
  • Lun Xu
    • 1
  • Kui-Wu Wu
    • 1
  • Ming-Gao Li
    • 2
  • Ling-Ling Zhu
    • 1
    • 3
  • Ming Fan
    • 1
    • 3
    • 4
    • 5
  1. 1.Department of Cognitive ScienceInstitute of Basic Medical SciencesBeijingChina
  2. 2.Navy Aviation and Diving Medical CenterNavy General Hospital of PLABeijingChina
  3. 3.Co-innovation Center of NeuroregenerationNantong UniversityNantongChina
  4. 4.Beijing Institute for Brain DisordersBeijingChina
  5. 5.Department of Brain Protection and PlasticityInstitute of Basic Medical SciencesBeijingChina

Personalised recommendations